Reuters Health Report: Trump says vaping decision coming shortly, hopes flavors can return to market fast

Visit Reuters.com for the latest news

Reuters Health Report Your Daily Briefing       Tweet       Share Trump says vaping decision coming shortly, hopes flavors can return to market fast U.S. President Donald Trump said on Tuesday that his administration would be unveiling a decision shortly on vaping, and said certain flavors would still come off the market but hopefully then return soon. U.S. vaping-related deaths rise to 55, cases of illness to 2,561 U.S. health officials said on Tuesday one more death occurred since last week from a mysterious respiratory illness tied to vaping, taking the total toll to 55. U.S. appeals court upholds risk payments to health insurers A U.S. appeals court upheld the validity of a federal program governing the payment of billions of dollars to insurers under the Affordable Care Act, reversing a lower court ruling that had prompted the White House to temporarily suspend payments. Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs Drugmakers including Pfizer Inc , GlaxoSmithKline PLC and Sanofi SA are planning to hike U.S. list prices on more than 200 drugs in the United States on Wednesday, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors. Large study of heart stenting vs surgery sparks controversy (Reuters Health) - A dispute over how to define a heart attack has prompted some European doctors to back away from the findings of a major study that concluded bypass surgery and stents are equally good at preventing heart disease deaths when a major heart artery is clogged. Physical activity linked to sperm quality (Reuters Health) - Healthy young men who exercise regularly may have better quality semen than their sedentary peers, a study of sperm donors suggests. Auto plant closures tied to surge in opioid overdose deaths (Reuters Health) - Opioid overdose deaths have spiked in the wake of automotive assembly plant closures across the U.S. South and Midwest, a new study suggests. China approves home-grown vaccines, offering alternative to global drugmakers' products China has approved a pneumonia vaccine developed by Chinese drugmaker Walvax Biotechnology's unit, its National Medical Products Administration said in a notice on Tuesday, offering an alternative to one of Pfizer's best-selling products Prevnar 13. Chinese officials investigate cause of pneumonia outbreak in Wuhan Chinese health authorities said they are investigating 27 cases of viral pneumonia in the central city of Wuhan, after rumors on social media suggested the outbreak could be linked to Severe Acute Respiratory Syndrome (SARS). California pharmacies rarely take back unused opioids (Reuters Health) - Only 1 in 10 California pharmacies have programs to take back unused prescription opioids and just one in five give consumers accurate disposal information, according to a study that suggests drugstores could do more to help combat substance abuse. Syrian med students trade translation services for e-learning access (Reuters Health) - Arabic-speaking medical students in war-torn Syria are providing translation services to an online educational company in exchange for free access to videos that teach clinical processes and procedures. Related Videos Star Wars-inspired prosthetic lets amputee 'feel' Health Times Square gears up for its annual NYE festivities Entertainment Introducing the all-new Reuters News app The new Reuters News app is here, redesigned from the ground up to fit your busy life. Get it now on iOS Your world. Your news. More Newsletters Get Reuters News App Get Reuters TV App               © 2020 Thomson Reuters. All rights reserved. 3 Times Square, New York, NY 10036 Email Preferences    |   Privacy Policy    |   Terms and Conditions